Compound Detail
CHEMBL5417448
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5417448 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BJVLYAFYRQFEFJ-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
452.5
MW (Da)
5.31
ALogP
7
HBA
4
HBD
120.4
PSA (Ų)
0.30
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.47
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Hep 3B2 | IC50 | = | 33540.0 | nM | 4.47 | Cytotoxicity against human Hep3B cells assessed as inhibition of cell proliferat... | 36549116 |
| HepG2 | IC50 | = | 39120.0 | nM | 4.41 | Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferat... | 36549116 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36549116 | 10.1016/j.ejmech.2022.115006 | Hep 3B2 | 1 |
| 36549116 | 10.1016/j.ejmech.2022.115006 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine